6H,8H-3,4-dihydropyrimido(4,5-c)(1,2)oxazin-7-one: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130855 |
| SCHEMBL ID | 332702 |
| MeSH ID | M0172375 |
| Synonym |
|---|
| base p |
| 1,3,4,8-tetrahydropyrimido[4,5-c]oxazin-7-one |
| 126128-35-6 |
| 6h,8h-3,4-dihydropyrimido(4,5-c)(1,2)oxazin-7-one |
| 3h-pyrimido(4,5-c)(1,2)oxazin-7(1h)-one, 4,6-dihydro- |
| SCHEMBL332702 |
| DTXSID20155086 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.46) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||